期刊论文详细信息
Lipids in Health and Disease
Enhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats
Lena Burri1  Clive R Bramham2  Debabrata Panja2  Anaïs Duffaud3  Michaël Messaoudi3  Kjetil Berge1  Karin Wibrand2 
[1] Aker Biomarine ASA, Fjordalleen 16, Oslo NO-0115, Norway;Department of Biomedicine and KG Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Jonas Lies vei 91, Bergen, NO-5009, Norway;ETAP-Applied Ethology Department of Neuropsychopharmacology, 13 rue Bois de la Champelle, Vandoeuvre-lès-Nancy, 54500, France
关键词: Phospholipids;    Fatty acids;    Omega-3;    Krill oil;    Imipramine;    Depression;    Cognition;    BDNF;   
Others  :  1160099
DOI  :  10.1186/1476-511X-12-6
 received in 2012-11-27, accepted in 2013-01-19,  发布年份 2013
PDF
【 摘 要 】

Background

The purpose of the study was to evaluate the effects of krill oil (KO) on cognition and depression-like behaviour in rats.

Methods

Cognition was assessed using the Aversive Light Stimulus Avoidance Test (ALSAT). The Unavoidable Aversive Light Stimulus (UALST) and the Forced Swimming Test (FST) were used to evaluate the antidepressant-like effects of KO. Imipramine (IMIP) was used as the antidepressant reference substance.

Results

After 7 weeks of KO intake, both males and females treated with KO were significantly better in discriminating between the active and the inactive levers in the ALSAT from day 1 of training (p<0.01). Both KO and IMIP prevented resignation/depression on the third day in the UALST. Similarly, a shorter immobility time was observed for the KO and IMIP groups compared to the control in the FST (p<0.001). These data support a robust antidepressant-like potential and beneficial cognitive effect of KO. Changes in expression of synaptic plasticity-related genes in the prefrontal cortex and hippocampus were also investigated. mRNA for brain-derived neurotrophic factor (Bdnf) was specifically upregulated in the hippocampus of female rats receiving 7 weeks of KO supplementation (p=0.04) and a similar trend was observed in males (p=0.08). Males also exhibited an increase in prefrontal cortex expression of Arc mRNA, a key protein in long-term synaptic plasticity (p=0.05). IMIP induced clear effects on several plasticity related genes including Bdnf and Arc.

Conclusions

These results indicate that active components (eicosapentaenoic acid, docosahexaenoic acid and astaxanthin) in KO facilitate learning processes and provide antidepressant-like effects. Our findings also suggest that KO might work through different physiological mechanisms than IMIP.

【 授权许可】

   
2013 Wibrand et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150410093738747.pdf 939KB PDF download
Figure 7. 26KB Image download
Figure 6. 39KB Image download
Figure 5. 40KB Image download
Figure 4. 67KB Image download
Figure 3. 55KB Image download
Figure 2. 55KB Image download
Figure 1. 74KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】
  • [1]Siriwardhana N, Kalupahana NS, Moustaid-Moussa N: Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res 2012, 65:211-222.
  • [2]Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F: Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 2012, 107(Suppl 2):S201-S213.
  • [3]Miles EA, Calder PC: Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 2012, 107(Suppl 2):S171-S184.
  • [4]Rontoyanni VG, Sfikakis PP, Kitas GD, Protogerou AD: Marine n-3 fatty acids for cardiovascular risk reduction and disease control in rheumatoid arthritis: "kill two birds with one stone"? Curr Pharm Des 2012, 18:1531-1542.
  • [5]O'Brien JS, Sampson EL: Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 1965, 6:545-551.
  • [6]Gamoh S, Hashimoto M, Hossain S, Masumura S: Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 2001, 28:266-270.
  • [7]Gamoh S, Hashimoto M, Sugioka K, Shahdat Hossain M, Hata N, Misawa Y, Masumura S: Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999, 93:237-241.
  • [8]Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L: Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 2005, 35:691-699.
  • [9]Jarrard LE: On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 1993, 60:9-26.
  • [10]Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ: Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005, 62:397-408.
  • [11]Videbech P, Ravnkilde B: Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004, 161:1957-1966.
  • [12]Lin PY, Huang SY, Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010, 68:140-147.
  • [13]Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH: Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 2006, 163:1098-1100.
  • [14]Carlezon WA Jr, Mague SD, Parow AM, Stoll AL, Cohen BM, Renshaw PF: Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 2005, 57:343-350.
  • [15]DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI: One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 2006, 47:172-180.
  • [16]Huang SY, Yang HT, Chiu CC, Pariante CM, Su KP: Omega-3 fatty acids on the forced-swimming test. J Psychiatr Res 2008, 42:58-63.
  • [17]Park Y, Moon HJ, Kim SH: N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test. J Nutr Biochem 2012, 23:924-928.
  • [18]Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R: PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34:199-211.
  • [19]Alme MN, Wibrand K, Dagestad G, Bramham CR: Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast 2007, 2007:26496.
  • [20]Calabrese F, Molteni R, Racagni G, Riva MA: Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009, 34(Suppl 1):S208-216.
  • [21]Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
  • [22]Fumagalli F, Caffino L, Racagni G, Riva MA: Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Eur Neuropsychopharmacol 2009, 19:402-408.
  • [23]Kuipers SD, Bramham CR: Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 2006, 9:580-586.
  • [24]Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ: Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007, 61:187-197.
  • [25]Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P, Domenici E, Chao MV, Mannisto PT, Castren E: Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 2007, 32:2152-2162.
  • [26]Winther B, Hoem N, Berge K, Reubsaet L: Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba. Lipids 2011, 46:25-36.
  • [27]Tou JC, Jaczynski J, Chen YC: Krill for human consumption: nutritional value and potential health benefits. Nutr Rev 2007, 65:63-77.
  • [28]Nishioka Y, Oyagi A, Tsuruma K, Shimazawa M, Ishibashi T, Hara H: The antianxiety-like effect of astaxanthin extracted from Paracoccus carotinifaciens. Biofactors 2011, 37:25-30.
  • [29]Zhang X, Pan L, Wei X, Gao H, Liu J: Impact of astaxanthin-enriched algal powder of Haematococcus pluvialis on memory improvement in BALB/c mice. Environ Geochem Health 2007, 29:483-489.
  • [30]Gamoh S: Krill-derived phospholipids rich in n-3 fatty acid improve spatial memory in adult rats. J Agric Sci 2011, 3:3-12.
  • [31]Bisson JF, Nejdi A, Rozan P, Hidalgo S, Lalonde R, Messaoudi M: Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats. Br J Nutr 2008, 100:94-101.
  • [32]Rozan P, Deremaux L, Wils D, Nejdi A, Messaoudi M, Saniez MH: Impact of sugar replacers on cognitive performance and function in rats. Br J Nutr 2008, 100:1004-1010.
  • [33]Messaoudi M, Tricoire A, Jung PH, Desor D, Mocaer E, Lesourd M: Effects of alnespirone (S 20499) in the depression model (Unavoidable aversive light stimulus test) in rats. Eur Neuropsychopharmacol 1996, 6:52.
  • [34]Hughes RN, Pither JM: Chronic imipramine effects on exploratory behavior in rats. Pharmacol Biochem Behav 1987, 27:359-362.
  • [35]Messaoudi M, Bisson JF, Nejdi A, Rozan P, Javelot H: Antidepressant-like effects of a cocoa polyphenolic extract in Wistar-Unilever rats. Nutr Neurosci 2008, 11:269-276.
  • [36]Satoh A, Tsuji S, Okada Y, Murakami N, Urami M, Nakagawa K, Ishikura M, Katagiri M, Koga Y, Shirasawa T: Preliminary Clinical Evaluation of Toxicity and Efficacy of A New Astaxanthin-rich Haematococcus pluvialis Extract. J Clin Biochem Nutr 2009, 44:280-284.
  • [37]Shaldubina A, Nemets B, Bersudsky Y: Lack of effect of eicosapentaenoic acid in the Porsolt forced swimming test model of depression. Acta Neuropsychiatrica 2002, 14:203-206.
  • [38]Di Marzo V, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Bisogno T, Collu M, Batetta B, et al.: Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 2010, 20:231-235.
  • [39]Burri L, Hoem N, Banni S, Berge K: Review. Marine omega-3 phospholipids: metabolism and biological activities. Int J Mol Sci 2012, 13:15401-15419.
  • [40]Grimstad T, Bjorndal B, Cacabelos D, Aasprong OG, Janssen EA, Omdal R, Svardal A, Hausken T, Bohov P, Portero-Otin M, et al.: Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scand J Gastroenterol 2012, 47:49-58.
  • [41]Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, et al.: Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005, 90:2522-2530.
  • [42]Maes M: The immunoregulatory effects of antidepressants. Hum Psychopharmacol 2001, 16:95-103.
  • [43]Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961-966.
  • [44]Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH: Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry 2003, 54:906-914.
  • [45]Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, et al.: A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002, 7:942-947.
  • [46]Genest J: C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol 2010, 26(Suppl A):41A-44A.
  • [47]Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F: Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005, 4:371-380.
  • [48]Deutsch L: Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. J Am Coll Nutr 2007, 26:39-48.
  • [49]Park JS, Chyun JH, Kim YK, Line LL, Chew BP: Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond) 2010, 7:18. BioMed Central Full Text
  • [50]Castren E, Voikar V, Rantamaki T: Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007, 7:18-21.
  • [51]Vines A, Delattre AM, Lima MM, Rodrigues LS, Suchecki D, Machado RB, Tufik S, Pereira SI, Zanata SM, Ferraz AC: The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 2012, 62:184-191.
  • [52]Wu A, Ying Z, Gomez-Pinilla F: The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J Neurotrauma 2011, 28:2113-2122.
  • [53]Delion S, Chalon S, Guilloteau D, Lejeune B, Besnard JC, Durand G: Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res 1997, 38:680-689.
  • [54]Ikemoto A, Nitta A, Furukawa S, Ohishi M, Nakamura A, Fujii Y, Okuyama H: Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett 2000, 285:99-102.
  • [55]Rao JS, Ertley RN, Lee HJ, DeMar JC Jr, Arnold JT, Rapoport SI, Bazinet RP: n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007, 12:36-46.
  • [56]Wibrand K, Messaoudi E, Havik B, Steenslid V, Lovlie R, Steen VM, Bramham CR: Identification of genes co-upregulated with Arc during BDNF-induced long-term potentiation in adult rat dentate gyrus in vivo. Eur J Neurosci 2006, 23:1501-1511.
  • [57]Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B, Panja D, Schubert M, Soule J, Tiron A, Wibrand K: The Arc of synaptic memory. Exp Brain Res 2010, 200:125-140.
  • [58]Shepherd JD, Bear MF: New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci 2011, 14:279-284.
  • [59]Gil-Bea FJ, Solas M, Mateos L, Winblad B, Ramirez MJ, Cedazo-Minguez A: Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation. Hippocampus 2011, 21:999-1009.
  • [60]Soule J, Alme M, Myrum C, Schubert M, Kanhema T, Bramham CR: Balancing Arc synthesis, mRNA decay, and proteasomal degradation: maximal protein expression triggered by rapid eye movement sleep-like bursts of muscarinic cholinergic receptor stimulation. J Biol Chem 2012, 287:22354-22366.
  • [61]Teber I, Kohling R, Speckmann EJ, Barnekow A, Kremerskothen J: Muscarinic acetylcholine receptor stimulation induces expression of the activity-regulated cytoskeleton-associated gene (ARC). Brain Res Mol Brain Res 2004, 121:131-136.
  • [62]Blusztajn JK, Liscovitch M, Richardson UI: Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line. Proc Natl Acad Sci USA 1987, 84:5474-5477.
  • [63]Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Saito H, Watanabe S, et al.: Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997, 58:1123-1129.
  • [64]Messaoudi M, Lalonde R, Nejdi A, Bisson JF, Rozan P, Javelot H, Schroeder H: The effects of Garum Armoricum on elevated-plus maze and conditioned light extinction tests in rats. Curr Topics Nutraceutical Res 2008, 6:41-46.
  • [65]Porsolt RD, Anton G, Blavet N, Jalfre M: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47:379-391.
  • [66]Porsolt RD, Le Pichon M, Jalfre M: Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
  • [67]Butterweck V, Nishibe S, Sasaki T, Uchida M: Antidepressant effects of apocynum venetum leaves in a forced swimming test. Biol Pharm Bull 2001, 24:848-851.
  • [68]Andersen CL, Jensen JL, Orntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64:5245-5250.
  文献评价指标  
  下载次数:36次 浏览次数:18次